Abundance Wealth Counselors’s GSK GSK Stock Holding History

Abundance Wealth Counselors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.46M	Buy	65,979 +32,848	+99%	+$1.74M	0.22%	62
2026 Q1	$1.83M	Sell	33,131 -1,536	-4%	-$83.2K	0.26%	56
2025 Q4	$1.7M	Buy	34,667 +111	+0.3%	+$5.18K	0.29%	57
2025 Q3	$1.49M	Buy	34,556 +928	+3%	+$36.2K	0.26%	68
2025 Q2	$1.29M	Buy	33,628 +8,226	+32%	+$314K	0.24%	69
2025 Q1	$984K	Buy	25,402 +4,391	+21%	+$161K	0.21%	88
2024 Q4	$711K	Sell	21,011 -1,404	-6%	-$50.5K	0.15%	101
2024 Q3	$916K	Buy	22,415 +731	+3%	+$29.9K	0.19%	89
2024 Q2	$835K	Buy	21,684 +1,868	+9%	+$78.6K	0.38%	50
2024 Q1	$850K	Buy	19,816 +1,343	+7%	+$55.4K	0.2%	81
2023 Q4	$685K	Buy	18,473 +1,957	+12%	+$70.3K	0.18%	89
2023 Q3	$599K	Buy	16,516 +1,273	+8%	+$45.2K	0.17%	88
2023 Q2	$543K	Sell	15,243 -11	-0.1%	-$395	0.28%	41
2023 Q1	$543K	Buy	+15,254	New	+$534K	0.14%	99
2021 Q2	–	Sell	-80	Closed	-$4K	–	197
2021 Q1	$4K	Buy	+80	New	+$3.63K	﹤0.01%	299

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Abundance Wealth Counselors's GSK Position: Q2 2026 in Review

Abundance Wealth Counselors increased its GSK (GSK) stake by 99% in Q2 2026, buying an estimated $1.74M and bringing the position to 65,979 shares worth $3.46M. The position accounts for 0.22% of the portfolio, ranked #62.

Abundance Wealth Counselors first reported a position in GSK in Q1 2021 and has held it in 15 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Abundance Wealth Counselors held 65,979 shares of GSK worth $3.46M as of Q2 2026.
Abundance Wealth Counselors bought 32,848 GSK shares in Q2 2026, an estimated $1.74M.
GSK made up 0.22% of Abundance Wealth Counselors's portfolio in Q2 2026, its #62 holding.
Abundance Wealth Counselors first reported a position in GSK in Q1 2021 and has held it in 15 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.